MiniMed™ 780G System
Advanced Hybrid Closed Loop system for people living with type 1 diabetes
It’s called MiniMed™ 780G and it has improved my quality of life tremendously.
Nicole
MiniMed™ 780G system user
Our Insulin management solutions
Insulin Pump Therapy
Self-adjusting insulin pump
The MiniMed™ 780G system is a fully integrated system that automatically adjusts insulin delivery to your needs day and
Fewer injections compared to
MiniMed™ 780G system helps people spend on average 76% of time in target
Multiple Daily Injection Therapies
What is a Smart MDI System?
The Smart MDI system combines the power of our latest innovation in continuous glucose monitoring (CGM), Guardian™ 4
Discover WeCare
WeCare - here for your diabetes journey
We are always here to support you, offering personalised onboarding programs and 24/7 hour support. We also have a mobile app to help make life easier for you.
Portfolio
We’ve developed a robust portfolio of life-transforming technologies that leverage data to deliver personalized insights, so you can take on each day with confidence.
Expertise
With our comprehensive, flexible offerings, our empathetic service and support, you can live fully in the moment. We’re working to help you manage your type 1 diabetes, our way.
- Medtronic data on file. Pivotal Trial (Age 14-75). N=157. 2020; 16 US sites
- Based on the recommended MiniMed™Mio™ Advance and MiniMed™Quick-set™ insulin infusion set change every 2-3 days compared to 4 injections a day for 30 days
- Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- 1.Carlson AL, et al. Diab Tech and Therap. 2021; DOI 10.1089/dia.2021.0319
- 2.Collyns OJ, et al. Diabetes Care. 2021;44(4):969-975.
- 3.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- * MDI = Multiple Daily Injections
- ** Time in Range is the percentage of time that people with type 1 diabetes spend in the optimal glycemic range of 70-180 mg/dL (3.9-10 mmol/L).
- # Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. one infusion set change every two to three days.
*** Time in Range is the percentage of time that people with type 1 diabetes spend in the optimal glycemic range of 70-180 mg/dL (3.9-10 mmol/L).
* Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.